Key facts
- Notable investors include Shenzhen Yifeng Investment Management Enterprise.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhuzhao Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhuzhao Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhuzhao Biotechnology
Operator of a research and clinical facility intended for ophthalmic and cerebrovascular disease. The company focuses on the research of new targets and mechanisms of fundus blood vessels and cerebrovascular diseases, thereby promoting the development and transformation of innovative drugs and innovative diagnostic products.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2023
- Website
- zzbiot.com/
- Ownership
- Privately Held (backing)
Zhuzhao Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhuzhao Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhuzhao Biotechnology in its N-PORT filings yet. We sweep new filings monthly.